- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03079258
Physical Activity and Vascular Health During Pregnancy
February 27, 2019 updated by: Áine Brislane, Liverpool John Moores University
Can Physical Activity During Pregnancy Improve Maternal and Offspring Vascular Health?
The aim of this study is to determine the effect of aerobic exercise on maternal and offspring vascular health.
Study Overview
Detailed Description
The study will comprise of a randomised pilot trial to assess the effect of a moderate intensity exercise intervention on maternal and offspring vascular health.
Participants will be recruited in the first trimester (T1, 10-12 weeks' gestation), and will be randomized to either a 24-week, structured and partially supervised, gym-based exercise intervention beginning in trimester 2 (T2) through to trimester 3 (T3), or a non-exercise control group who receive normal clinical care.
The inclusion of this non-exercise control group is critical in allowing us to create an understanding of the adaptation of the vascular system during a normal (non-exercising) pregnancy, and also determining the physical activity and sedentary behaviour engaged in during normal healthy pregnancy.
All participants will be asked to attend the laboratory at Liverpool John Moores University on 4 separate occasions synchronised with the end point of each trimester and then within four weeks of delivery.
Maternal vascular health, physical activity, sedentary behaviour and fitness will be assessed during each time point throughout pregnancy while the fourth visit will comprise of an offspring vascular assessment.
The investigators will also gain information on delivery outcomes including pre-term delivery, complications during labour, induction of labour, caesarean sections and post-partum haemorrhage via medical notes at the Liverpool Women's NHS Foundation Trust.
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L33AF
- Research Institute for Sport and Exercise Sciences (RISES)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Healthy pregnant female
- No history of cardiovascular disease, gestational diabetes or pre-eclampsia
- Single gestation
- Not on medication affecting cardiovascular health
- A non-smoker for at least 6 months
- Participating in structured exercise <twice/week
- BMI <30kg/m^2 -
Exclusion Criteria:
- Royal College of Obstetricians and Gynaecologists (RCOG) contraindications for pregnancy
- Pregnant by in-vitro fertilisation (IVF)exercise
- BMI >30kg/m^2
- >45 years old
- Structured exercise >twice/week
- Multiple gestation
- Disability preventing ambulation
- Currently smoking or smoking within past 6 months prior to pregnancy
- Non-English speaking women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise
Participants randomized to the exercise intervention group will be required to complete a 24-wk partially supervised exercise programme consisting of 3-4 sessions per week of 15 minutes progressing to 30 minutes over time.
|
Previously inactive pregnant women will be asked to complete 3-4 sessions of aerobic exercise each week for 24 weeks of 15-30 minutes in duration.
|
|
No Intervention: Control
Those randomized to the control group will continue with their standard care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Vascular Function
Time Frame: Change from baseline at week 24 and 36 of pregnancy
|
Vascular function will be measured via endothelial-dependent flow-mediated dilation (FMD) of the brachial and femoral arteries and reported as percentage change.
|
Change from baseline at week 24 and 36 of pregnancy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sedentary behaviour
Time Frame: Change from baseline at week 24 and 36 of pregnancy
|
Sedentary behaviour will be measured using an inclinometer at the end of each trimester for a period of 7 days in line with the accelerometer monitoring and will be reported in minutes.
|
Change from baseline at week 24 and 36 of pregnancy
|
|
Change in Physical activity
Time Frame: Change from baseline at week 24 and 36 of pregnancy
|
Physical activity will be monitored for a period of 7 days using accelerometry at the end of each trimester.
|
Change from baseline at week 24 and 36 of pregnancy
|
|
Incidence of Pregnancy specific outcomes
Time Frame: Following delivery and within 4 weeks
|
Following delivery the investigator will obtain information regarding pregnancy specific outcomes including pre-term birth, delivery complications, induction of labour, caesarean section and post-partum haemorrhage via medical notes at the collaborating hospital.
|
Following delivery and within 4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Offspring Vascular Structure
Time Frame: Assessed within 4 weeks of delivery
|
Offspring vascular structure will be assessed at the abdominal aorta site using ultrasound imaging.
Wall thickness will be measured at three different angles of an optimised ultrasound image.
The image will be adjusted so that artery wall thickness can be clearly seen and a 30 second recording taken at three different angles.
The average of the three angles will be calculated for each artery.
Results will be reported as change in millimetres at each time point for each artery assessed.
|
Assessed within 4 weeks of delivery
|
|
Change in Cerebrovascular Function
Time Frame: Change from baseline at week 24 and 36 of pregnancy
|
Change in cerebrovascular function will be assessed using transcranial Doppler ultrasound to measure brain blood flow velocity.
|
Change from baseline at week 24 and 36 of pregnancy
|
|
Change in Vascular Structure
Time Frame: Change from baseline at week 24 and 36 of pregnancy
|
Vascular structure will be measured at carotid, femoral and brachial arteries using ultrasound imaging to clearly visualise the artery.
The image will be adjusted so that artery wall thickness can be clearly seen and a 30 second recording taken at three different angles.
The average of the three angles will be calculated for each artery.
Results will be reported as change in millimetres at each time point for each artery assessed.
|
Change from baseline at week 24 and 36 of pregnancy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Nicola Hopkins, PhD, Dr.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 23, 2017
Primary Completion (Anticipated)
May 30, 2019
Study Completion (Anticipated)
August 3, 2019
Study Registration Dates
First Submitted
February 28, 2017
First Submitted That Met QC Criteria
March 8, 2017
First Posted (Actual)
March 14, 2017
Study Record Updates
Last Update Posted (Actual)
February 28, 2019
Last Update Submitted That Met QC Criteria
February 27, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17/NW/0056
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Lifestyle
-
Eindhoven University of TechnologyCompletedLifestyle | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryBelgium
-
Stanford UniversityActive, not recruiting
-
University of California, San DiegoCompleted
-
Loughborough UniversityBritish Heart FoundationCompletedSedentary Lifestyle | Sedentary Behavior | Diet Habit
-
Taipei Medical University WanFang HospitalRecruitingLifestyle, SedentaryTaiwan
-
Brandeis UniversityNational Institute on Aging (NIA)Completed
-
University of MiamiCompletedSedentary LifestyleUnited States
-
University of PrimorskaInnorenew CoEUnknown
-
Chinese University of Hong KongCompletedVirtual Trainer System (3rd Version) for Physical Activity Promotion in Middle-aged Hong Kong AdultsSedentary LifestyleHong Kong
-
VakgroepBewegingsEnSportwetenschappenUniversity GhentCompleted
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
University College CorkRecruitingDepressive Disorder, MajorIreland